JP2003534310A - 塩酸セルトラリンの新規な非結晶形態 - Google Patents

塩酸セルトラリンの新規な非結晶形態

Info

Publication number
JP2003534310A
JP2003534310A JP2001586239A JP2001586239A JP2003534310A JP 2003534310 A JP2003534310 A JP 2003534310A JP 2001586239 A JP2001586239 A JP 2001586239A JP 2001586239 A JP2001586239 A JP 2001586239A JP 2003534310 A JP2003534310 A JP 2003534310A
Authority
JP
Japan
Prior art keywords
sertraline hydrochloride
solvent
amorphous
mixture
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001586239A
Other languages
English (en)
Japanese (ja)
Inventor
ケーラ，ブリジ
ロハタギ，アミット
タイギ，オム，ダット
クマール，ヤテンドラ
Original Assignee
ランバクシー ラボラトリーズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ランバクシー ラボラトリーズ リミテッド filed Critical ランバクシー ラボラトリーズ リミテッド
Publication of JP2003534310A publication Critical patent/JP2003534310A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2001586239A 2000-05-26 2001-05-24 塩酸セルトラリンの新規な非結晶形態 Pending JP2003534310A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN540/DEL/2000 2000-05-26
IN540DE2000 IN192343B (enExample) 2000-05-26 2000-05-26
PCT/IB2001/000909 WO2001090049A1 (en) 2000-05-26 2001-05-24 Novel amorphous form of sertraline hydrochloride

Publications (1)

Publication Number Publication Date
JP2003534310A true JP2003534310A (ja) 2003-11-18

Family

ID=11097055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001586239A Pending JP2003534310A (ja) 2000-05-26 2001-05-24 塩酸セルトラリンの新規な非結晶形態

Country Status (11)

Country Link
US (1) US20040063792A1 (enExample)
EP (1) EP1289928A4 (enExample)
JP (1) JP2003534310A (enExample)
CN (1) CN1438989A (enExample)
AU (1) AU2001256595A1 (enExample)
BR (1) BR0111193A (enExample)
CA (1) CA2409856A1 (enExample)
CZ (1) CZ20023903A3 (enExample)
IN (1) IN192343B (enExample)
SK (1) SK17272002A3 (enExample)
WO (1) WO2001090049A1 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014510038A (ja) * 2011-01-21 2014-04-24 エーブリー デニソン コーポレイション クロルヘキシジングルコネート含有溶媒接着剤
US10456498B2 (en) 2013-02-07 2019-10-29 Avery Dennison Corporation Antimicrobial adhesives having improved properties
US11058793B2 (en) 2011-05-16 2021-07-13 Avery Dennison Corporation Adhesive containing microparticles
US11213432B2 (en) 2013-03-15 2022-01-04 Avery Dennison Corporation Transparent cover dressing application system and inclusion of label strip
US11337940B2 (en) 2014-06-05 2022-05-24 Avery Dennison Corporation Articles with active agent concentrated at the substrate contacting surface and related methods

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500987B1 (en) 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
US6495721B1 (en) 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
YU47902A (sh) 1999-12-21 2005-11-28 Teva Pharmaceutical Industries Ltd. Novi polimorfi sertralin hidrohlorida, postupci za njihovo dobijanje, preparati koji ih sadrže i postupci za njihovu upotrebu
US7067700B2 (en) 2001-05-31 2006-06-27 Fermion Oy Process for preparing sertraline hydrochloride polymorphic form II
EP1499581A1 (en) 2002-04-29 2005-01-26 Teva Pharmaceutical Industries Ltd. Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof
JP2007502329A (ja) 2003-05-23 2007-02-08 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド セルトラリン組成物
US7173153B2 (en) * 2003-07-15 2007-02-06 Recordati Industria Chimica E. Farmaceutica S.P.A. Sertraline hydrochloride form II and methods for the preparation thereof
EP1648854A1 (en) 2003-07-15 2006-04-26 RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. Methods for preparing sertraline hydrochloride polymorphs
US20060270859A1 (en) * 2005-01-27 2006-11-30 Santiago Ini Duloxetine HCl polymorphs
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
DE102008039271A1 (de) * 2007-12-23 2009-06-25 Euromed Sa Neuer Mariendistelextrakt, Verfahren zur Herstellung und Verwendung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5166437A (en) * 1989-03-03 1992-11-24 Orion-Yhtyma Oy Process for the preparation of fluoxetine
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5734083A (en) * 1996-05-17 1998-03-31 Torcan Chemical Ltd. Sertraline polymorph
JP2000026378A (ja) * 1998-07-03 2000-01-25 Sumika Fine Chemicals Co Ltd 塩酸セルトラリンの製法
IL143311A0 (en) * 1998-11-27 2002-04-21 Teva Pharma Sertraline hydrochloride polymorphs
US6500987B1 (en) * 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
TWI260315B (en) * 1999-10-29 2006-08-21 Ciba Sc Holding Ag Polymorphic forms of sertraline hydrochloride

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014510038A (ja) * 2011-01-21 2014-04-24 エーブリー デニソン コーポレイション クロルヘキシジングルコネート含有溶媒接着剤
US9764059B2 (en) 2011-01-21 2017-09-19 Avery Dennison Corporation Chlorhexidine gluconate containing solvent adhesive
US11058793B2 (en) 2011-05-16 2021-07-13 Avery Dennison Corporation Adhesive containing microparticles
US11707549B2 (en) 2011-05-16 2023-07-25 Avery Dennison Corporation Adhesive containing microparticles
US12036335B2 (en) 2011-05-16 2024-07-16 Avery Dennison Corporation Adhesive containing microparticles
US10456498B2 (en) 2013-02-07 2019-10-29 Avery Dennison Corporation Antimicrobial adhesives having improved properties
US11318223B2 (en) 2013-02-07 2022-05-03 Avery Dennison Corporation Antimicrobial adhesives having improved properties
US11213432B2 (en) 2013-03-15 2022-01-04 Avery Dennison Corporation Transparent cover dressing application system and inclusion of label strip
US11337940B2 (en) 2014-06-05 2022-05-24 Avery Dennison Corporation Articles with active agent concentrated at the substrate contacting surface and related methods
US12109180B2 (en) 2014-06-05 2024-10-08 Avery Dennison Corporation Articles with active agent concentrated at the substrate contacting surface and related methods

Also Published As

Publication number Publication date
CA2409856A1 (en) 2001-11-29
BR0111193A (pt) 2003-07-29
AU2001256595A1 (en) 2001-12-03
CN1438989A (zh) 2003-08-27
IN192343B (enExample) 2004-04-10
WO2001090049A1 (en) 2001-11-29
EP1289928A1 (en) 2003-03-12
US20040063792A1 (en) 2004-04-01
EP1289928A4 (en) 2005-06-08
SK17272002A3 (sk) 2003-05-02
CZ20023903A3 (cs) 2003-05-14

Similar Documents

Publication Publication Date Title
CN101679218B (zh) 晶体米诺环素碱及其制备方法
JP6211072B2 (ja) ダサチニブと、選択された共結晶形成剤とを含んでなる多成分結晶
JP2002531409A (ja) アジスロマイシンのエタノール付加物、その製造方法、及びその医薬製剤
RU2006121341A (ru) Кристаллические формы дигидрохлорида (6r)-l-эритро-тетрагидробиоптерина
JP2002514653A (ja) マクロライド製造の改善
KR20070072786A (ko) 무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법
EP1289928A1 (en) Novel amorphous form of sertraline hydrochloride
EP1485393B1 (en) 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
WO2016185485A2 (en) Process for the preparation of n-[4-[(3-chloro-4-fluoro phenyl) amino]-7-[[(3s)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4- (dimethyl amino)-(2e)-2-butenamide (2z)-2-butenedioate (1 :2) and its polymorphs thereof
JP2003516959A (ja) プラバスタチンナトリウムの新規フォーム
CN101098850B (zh) 西布曲明的无机酸盐
CN101563346A (zh) 制备阿巴卡韦的方法
WO2000071124A1 (en) Amorphous form of fexofenadine hydrochloride
US20070021444A1 (en) Valacyclovir polymorphs and a process for the preparation thereof
US20090202647A1 (en) Solid form of racemic rotigotine
JP2014521729A (ja) ピラゾロピリミジノン化合物の塩、多形体およびその薬物組成物、製造方法および応用
JP2003533512A (ja) トラセミドの新規多形ｖ
JP2001524548A (ja) ２−〔２−〔４−〔ビス（４−フルオロフェニル）メチル〕−１−ピペラジニル〕エトキシ〕酢酸ジヒドロクロリドの偽多形
JP2001502663A (ja) 置換バリンアミド誘導体の製造方法
JP2002532510A (ja) クラリスロマイシンの製造に於けるマクロライド中間体
CN113603692B (zh) 5型磷酸二酯酶抑制剂的多晶物及其制备方法和应用
US20060252789A1 (en) Amorphous moxifloxacin hydrochloride
JP2002529443A (ja) Ｌ−ドーパエチルエステルの製造方法
WO2004039352A2 (en) Amorphous form of losartan potassium
CA3094588A1 (en) Isothermal reactive crystallisation process for the preparation of a crystalline form of pimodivir hydrochloride hemihydrate